Dropout ‐ Studies with low risk of bias · patients with opioid detoxification
Any Psychosocial plus any Pharmacological leads to lower dropouts ‐ Only studies with low risk of bias objeive compared with any Pharmachological alone compared to (high certainty).
1 finding from 1 review
use of opiate during treatment ( · patients with opioid detoxification
Any Psychosocial plus any Pharmacological probably leads to lower use of opiate during the treatment objective compared with any Pharmachological alone compared to (moderate certainty).
1 finding from 1 review
Results at · patients with opioid detoxification
Any Psychosocial plus any Pharmacological probably leads to lower results at compared with any Pharmachological alone compared to (moderate certainty).
2 findings from 1 review
Compliance as clinical absences during the tratment objective · patients with opioid detoxification
Any Psychosocial plus any Pharmacological probably leads to lower compliance as clinical absences during the tratment objective compared with any Pharmachological alone compared to (moderate certainty).
1 finding from 1 review
Intervention not reported
Number completing detoxification · patients with opioid withdrawal
The intervention may leads to higher number completing detoxification (low certainty).
1 finding from 1 review
Intervention not reported
Number commencing naltrexone maintenance treatment ‐ Clonidine comparison · patients with opioid withdrawal
The intervention probably leads to higher number commencing naltrexone maintenance treatment ‐ Clonidine… (moderate certainty).
1 finding from 1 review
Intervention not reported
Number commencing naltrexone maintenance treatment ‐ Buprenorphine comparison · patients with opioid withdrawal
The intervention probably leads to higher number commencing naltrexone maintenance treatment ‐ Buprenorphine… (moderate certainty).
1 finding from 1 review
Intervention not reported
Retained in naltrexone maintenance treatment or abstinent at 12 weeks ‐ Tapered methadone comparison · patients with opioid withdrawal
The intervention showed no clear difference in retained in naltrexone maintenance treatment or abstinent at 12… (low certainty).
1 finding from 1 review
Intervention not reported
Retained in naltrexone maintenance treatment or abstinent at 12 weeks ‐ Clonidine comparison · patients with opioid withdrawal
The intervention probably leads to higher retained in naltrexone maintenance treatment or abstinent at 12… (moderate certainty).
1 finding from 1 review
Intervention not reported
Retained in naltrexone maintenance treatment or abstinent at 12 weeks ‐ Buprenorphine comparison · patients with opioid withdrawal
The intervention showed no clear difference in retained in naltrexone maintenance treatment or abstinent at 12… (moderate certainty).
1 finding from 1 review
Intervention not reported
Participants experiencing adverse effects · patients with opioid withdrawal
The intervention probably leads to higher participants experiencing adverse effects (moderate certainty).
1 finding from 1 review
Intervention not reported
Less than 300 events · patients with opioid withdrawal
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Alcohol withdrawal seizures objective · people with alcohol withdrawal
Benzodiazepine probably leads to lower alcohol withdrawal seizures objective compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events · people with alcohol withdrawal
Benzodiazepine showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Leaving the study early · people with alcohol withdrawal
Benzodiazepine showed no clear difference in dropouts compared with placebo (moderate certainty).
1 finding from 1 review
Alcohol withdrawal seizures ‐ Benzodiazepine vs. Other Drug · patients with
Benzodiazepine showed no clear difference in alcohol withdrawal seizures ‐ Benzodiazepine vs. Other Drug compared with other Drug for (moderate certainty).
1 finding from 1 review
Alcohol withdrawal seizures ‐ Benzodiazepine vs. Anticonvulsant · patients with
Benzodiazepine showed no clear difference in alcohol withdrawal seizures ‐ Benzodiazepine vs. Anticonvulsant compared with other Drug for (moderate certainty).
1 finding from 1 review
Adverse events ‐ Benzodiazepine vs. Other Drug · patients with
Benzodiazepine showed no clear difference in adverse events ‐ Benzodiazepine vs. Other Drug compared with other Drug for (low certainty).
1 finding from 1 review
Adverse events ‐ Benzodiazepine vs. Anticonvulsant · patients with
Benzodiazepine showed no clear difference in adverse events ‐ Benzodiazepine vs. Anticonvulsant compared with other Drug for (high certainty).
1 finding from 1 review
Dropouts ‐ Benzodiazepine vs. Other Drug · patients with
Benzodiazepine showed no clear difference in dropouts ‐ Benzodiazepine vs. Other Drug compared with other Drug for (moderate certainty).
1 finding from 1 review